Contact this trialFirst, we need to learn more about you.
Endothelin Receptor Antagonist
Combination Chemotherapy for Pancreatic Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial studies the side effects and best dose of bosentan when given with gemcitabine and nab-paclitaxel for the treatment of unresectable pancreatic cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.